114 related articles for article (PubMed ID: 8347493)
1. Smear misclassification in a cervical cancer screening programme.
Lynge E; Arffmann E; Poll P; Anderson PK
Br J Cancer; 1993 Aug; 68(2):368-73. PubMed ID: 8347493
[TBL] [Abstract][Full Text] [Related]
2. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
Lynge E; Arffmann E; Poll P; Andersen PK
Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
[TBL] [Abstract][Full Text] [Related]
3. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark.
Lynge E; Poll P
Am J Epidemiol; 1986 Sep; 124(3):345-52. PubMed ID: 3740035
[TBL] [Abstract][Full Text] [Related]
5. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
6. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
Mitchell H; Hocking J; Saville M
Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
[TBL] [Abstract][Full Text] [Related]
7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
8. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
9. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
10. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
11. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
12. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
13. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
14. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
15. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
16. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
17. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
18. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
[TBL] [Abstract][Full Text] [Related]
19. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
Clarke EA; Anderson TW
Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
[TBL] [Abstract][Full Text] [Related]
20. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
